Advertisement

Accelerated Partial Breast Irradiation

  • Ben Wilkinson
  • Laurie Cuttino
  • Dorin Todor
  • Frank Vicini
Chapter
Part of the Medical Radiology book series (MEDRAD)

Abstract

Accelerated partial breast irradiation has become an important component of the management of early-stage breast cancer. While local control following APBI continues to be excellent with acceptable rates of acute and late toxicities, further refinement of patient selection guidelines and completion of the ongoing Phase III trials remain priorities for this growing segment of radiation oncology.

Keywords

Planning Target Volume Clinical Target Volume Accelerate Partial Breast Irradiation Ipsilateral Breast Tumor Recurrence Whole Breast Irradiation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

We wish to acknowledge Prof. John Yarnold and Dr. Ellen Donovan from Royal Marsden Hospital and Dr. Charlotte coles from Cambridge University Hospitals for their important contributions to this chapter regarding ongoing clinical trials and radiotherapy techniques in Europe. Without their assistance, this chapter would not have been possible.

References

  1. American Association of Physicists in Medicine (AAPM). Task group no. 43 Report. http://www.aapm.org. Accessed 20 Dec 2010
  2. American Brachytherapy Society Breast Brachytherapy Task Force (2010). Breast brachytherapy as a boost; accelerated partial breast irradiation (APBI). http://www.americanbrachytherapy.org/resources/abs_breast_brachytherapy_taskgroup.pdf. Accessed 18 Aug 2010
  3. American Society of Breast Surgeons (2008) Consensus Statement for accelerated partial breast irradiation. http://www.breastsurgeons.org/statements/PDF_Statements/APBI_statement_revised_100708.pdf. Accessed 18 Aug 2010
  4. Antonucci JV, Wallace M, Goldstein NS et al (2009) Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys 74(2):447–452PubMedCrossRefGoogle Scholar
  5. Arthur DW, Vicini FA (2005) Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 23:1726–1735PubMedCrossRefGoogle Scholar
  6. Arthur DW, Vicini FA, Kuske RR et al (2002) Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 1:184–190PubMedCrossRefGoogle Scholar
  7. Arthur D (2003a) Accelerated partial breast irradiation: a change in treatment paradigm for early stage breast cancer. J Surg Oncol 84(4):185–191PubMedCrossRefGoogle Scholar
  8. Arthur D, Vicini FA, Kuske RR et al (2003b) Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2:124–130PubMedCrossRefGoogle Scholar
  9. Arthur DW, Winter K, Kuske RR et al (2008) A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95–17. Int J Radiat Oncol Biol Phys 72(2):467–473PubMedCrossRefGoogle Scholar
  10. Astrahan MA, Jozsef G, Streeter OE (2004) Optimization of mammosite therapy. Int J Radiat Oncol Biol Phys 58(1):220–232PubMedCrossRefGoogle Scholar
  11. Athas WF, Adams-Cameron M, Hunt WC et al (2000) Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92(3):269–271PubMedCrossRefGoogle Scholar
  12. Baglan KL, Sharpe MB, Jaffray D et al (2003) Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 55(2):302–311PubMedCrossRefGoogle Scholar
  13. Baillet F, Housset M, Maylin C et al (1990) The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int J Radiat Oncol Biol Phys 19:1131–1133PubMedCrossRefGoogle Scholar
  14. Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol 25(22):3259–3265PubMedCrossRefGoogle Scholar
  15. Baxter NN, Virning BA, Durham SB et al (2004) Trends in treatment of ductal carcinoma in situ of the breast. J Nat Cancer Inst 96:443–448PubMedCrossRefGoogle Scholar
  16. Beal K, Cohen GN, McCormick B et al (2009) Intraoperative radiation therapy during breast-conserving surgery; the memorial Sloan–Kettering cancer center technique. In: Wazer D, Arthur D, Vicini F (eds) Accelerated Partial Breast Irradiation. Springer, Berlin 367–376Google Scholar
  17. Belletti B, Vaidya JS et al (2008) Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res 14(5):1324–1332CrossRefGoogle Scholar
  18. Benitez PR, Keisch ME, Vicini F et al (2007) Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 194:456–462PubMedCrossRefGoogle Scholar
  19. Bentzen SM, Yarnold JR (2010) Reports of unexpected late side effects of accelerated partial breast irradiation-radiobiological considerations. Int J Radiat Oncol Biol Phys 77(4):969–973PubMedCrossRefGoogle Scholar
  20. Bentzen SM, Saunders MI, Dische S (1999) Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 53(3):219–226PubMedCrossRefGoogle Scholar
  21. Bentzen SM, Agrawal RK, Aird EG et al (2008a) The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371(9618):1098–1107CrossRefGoogle Scholar
  22. Bentzen SM, Agrawal RK, Aird EG et al (2008b) The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9(4):331–341CrossRefGoogle Scholar
  23. Brunt AM, Yarnold J (2009) A five fraction regimen for women with early breast cancer: first analysis of the randomized UK FAST trial. Eur J Canc Suppl 7:1Google Scholar
  24. Buchholz TA, Kuerer HM, Strom-Buchholz EA et al (2005) Is partial breast irradiation a step forward or backward? Semin Radiat Oncol 15(2):69–75PubMedCrossRefGoogle Scholar
  25. Cabioglu N, Hunt KK, Strom Buchholz EA et al (2005) Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 104(1):20–29PubMedCrossRefGoogle Scholar
  26. Chao KK, Vicini FA, Wallace M et al (2007) Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys 69(1):32–40PubMedCrossRefGoogle Scholar
  27. Chen PY, Wallace M, Mitchell C et al (2010) Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 76(4):991–997PubMedCrossRefGoogle Scholar
  28. Chino JP, Marks LB (2008) Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int J Radiat Oncol Biol Phys 70(3):916–920PubMedCrossRefGoogle Scholar
  29. Clark RM, McCulloch PB, Boolbol S et al (1992) Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683–689PubMedCrossRefGoogle Scholar
  30. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106PubMedGoogle Scholar
  31. Coles C, Yarnold J (2006) The IMPORT trials are launched. Clin Oncol (R Coll Radiol) 18(8):587–590CrossRefGoogle Scholar
  32. Coles CE, Yarnold J (2010) Localising the tumour bed in breast radiotherapy. Clin Oncol (R Coll Radiol) 22(1):36–38CrossRefGoogle Scholar
  33. Cuttino LW, Todor D, Arthur DW (2005) CT-guided multi-catheter insertion technique for partial breast brachytherapy: Reliable target coverage and dose homogeneity. Brachytherapy 4:10–17PubMedCrossRefGoogle Scholar
  34. Cuttino LW, Todor D, Pacyna L et al (2006) Three-dimensional conformal external beam radiotherapy (3D-CRT) for accelerated partial breast irradiation (APBI): what is the correct prescription dose? Am J Clin Oncol 29(5):474–478PubMedCrossRefGoogle Scholar
  35. Cuttino LW, Keisch M, Jenrette JM et al (2008) Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys 71:107–114PubMedCrossRefGoogle Scholar
  36. Dickler A, Kirk M et al (2004) Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 59(2):469–474PubMedCrossRefGoogle Scholar
  37. Dobelower RR, Merrick HW, Eltaki A et al (1989) Intraoperative electron beam therapy and external photon beam therapy with lumpectomy as primary treatment for early breast cancer. Ann Radiol (Paris) 32(6):497–501Google Scholar
  38. Edmundson GK, FA et al (2002) Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52(4):1132–1139PubMedCrossRefGoogle Scholar
  39. Faverly D, Holland R, Burgers L et al (1992) An original stereomicroscopic analysis of the mammary glandular tree. Virchows Arch A Pathol Anat Histopathol 421:115–119PubMedCrossRefGoogle Scholar
  40. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241PubMedCrossRefGoogle Scholar
  41. Fleming FJ, Hill AD, McDermott EW et al (2004) Intraoperative margin assessment and re-excision rate in breast conserving surgery. Eur J Surg Oncol 30:233–237PubMedCrossRefGoogle Scholar
  42. Formenti SC, Gidea-Addeo D, Goldberg JD et al (2007) Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 25(16):2236–2242PubMedCrossRefGoogle Scholar
  43. Goldstein NS, Kestin LL, Vicini FA et al (2003) Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinomas treated with breast-conservation therapy. A clinicopathologic study of 607 neoplasms from 586 patients. Am J Clin Pathol 120:500–527PubMedCrossRefGoogle Scholar
  44. Gujral DM, Sumo G, Owen JR et al (2010) Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries. Int J Radiat Oncol Biol Phys 79(1):19–25PubMedCrossRefGoogle Scholar
  45. Harris EJ, Donovan EM, Yarnold JR et al (2009) Characterization of target volume changes during breast radiotherapy using implanted fiducial markers and portal imaging. Int J Radiat Oncol Biol Phys 73(3):958–966PubMedCrossRefGoogle Scholar
  46. Hepel JT, Tokita M, MacAusland SG et al (2009) Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75(5):1290–1296PubMedCrossRefGoogle Scholar
  47. Holland R, Veling SH, Mravunac M et al (1985) Histologic multifocality of Tis, T1–T2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979–990PubMedCrossRefGoogle Scholar
  48. Holmes DR, Baum M, Joseph D et al (2007) The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg 194(4):507–510PubMedCrossRefGoogle Scholar
  49. Imamura H, Haga S, Shimizu T et al (2000) Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 62(3):177–184PubMedCrossRefGoogle Scholar
  50. Kaufman SA, DiPetrillo TA, Price LL et al (2007) Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy 6(4):286–292PubMedCrossRefGoogle Scholar
  51. Keisch M, Vicini F, Kuske RR et al (2003) Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55:289–293PubMedCrossRefGoogle Scholar
  52. King TA, Bolton JS, Kuske RR et al (2000) Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1, 2) breast cancer. Am J Surg 180(4):299–304PubMedCrossRefGoogle Scholar
  53. Kirby AM, Evans PM, Donovan EM et al (2010) Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry. Radiother Oncol 96(2):178–184PubMedCrossRefGoogle Scholar
  54. Kozak KR, Katz A, Adams J et al (2006) Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys 65:1572–1578PubMedCrossRefGoogle Scholar
  55. Krauss DJ, Kestin LL, Raff G et al (2005) MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys 61(4):1243–1250PubMedCrossRefGoogle Scholar
  56. Kurtz JM, Spitalier JM, Amalric R et al (1990) The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 18(1):87–93PubMedCrossRefGoogle Scholar
  57. Kuske RR (1999) Breast brachytherapy. Hematol Oncol Clin North Am 13:543–558PubMedCrossRefGoogle Scholar
  58. Kuske RR (2009) Brachytherapy techniques: the arizona approach. In: Wazer D, Arthur D, Vicini F (eds) Accelerated partial breast irradiation: techniques and clinical implementation. Springer, Berlin, pp 345–366Google Scholar
  59. Kuske RR, Winter K, Arthur DW et al (2006) Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95–17. Int J Radiat Oncol Biol Phys 65:45–51PubMedCrossRefGoogle Scholar
  60. Leonard CE, Tallhamer M, Johnson T et al (2007) Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 67(5):1291–1298PubMedCrossRefGoogle Scholar
  61. Livi L, Buonamici FB, Simontacchi G et al (2010) Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys 77(2):509–515PubMedCrossRefGoogle Scholar
  62. Luini A, Orecchia R, Gatti G et al (2005) The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat 93(1):55–59PubMedCrossRefGoogle Scholar
  63. Mannino M, Yarnold JR (2009) Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld? Radiother Oncol 90(1):14–22PubMedCrossRefGoogle Scholar
  64. Mayo Foundation for Education and Research (2010) Intraoperative radiation therapy (IORT). http://www.mayoclinic.org/IORT. Accessed 30 Sept 2010
  65. McGrath S, Antonucci J, Goldstein N et al (2010) Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation. Am J Clin Oncol 33(1):17–22PubMedCrossRefGoogle Scholar
  66. Morrow M (2002) Rational local therapy for breast cancer. N Engl J Med 347(16):1270–1271PubMedCrossRefGoogle Scholar
  67. Nattinger AB, Hoffman RG, Kneusel RT et al (2000) Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast conserving surgery. Lancet 356:1148–1153PubMedCrossRefGoogle Scholar
  68. PR Newswire, Inc. (2010) Hoag hospital launches intraoperative radiation therapy protocol for patients undergoing tissue-sparing breast cancer surgery. http://www.prnewswire.com. Accessed 30 Sept 2010
  69. Ohtake T, Abe R, Kimijima I et al (1995) Intraductal extension of primary invasive breast carcinoma treated by breast conserving surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 76:32–45PubMedCrossRefGoogle Scholar
  70. Ollila DW, Klauber-DeMore N, Tesche LJ et al (2007) Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol 14(2):660–669PubMedCrossRefGoogle Scholar
  71. Orecchia R, Ciocca M, Lazzari R et al (2003) Intraoperative radiation therapy with electrons (ELIOT) in early stage breast cancer. Breast 12:483–490PubMedCrossRefGoogle Scholar
  72. Orecchia R, Ivaldi GB, Leonardi MC (2009) APBI intraoperative technique with electrons. In: Wazer D, Arthur D, Vicini F (eds) Accelerated partial breast irradiation: techniques and clinical implementation Springer, Berlin, pp 345–366Google Scholar
  73. Owen JR, Ashton A et al (2006) Effect of radiotherapy fraction size on tumour control in patients with early–stage breast cancer after local tumour excision: long-term results of a randomized trial. Lancet Oncol 7:467–471PubMedCrossRefGoogle Scholar
  74. Perera F, Yu E, Engel J et al (2003) Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys 57:1239–1246PubMedCrossRefGoogle Scholar
  75. Polgar C, Fodor J, Orosz Z et al (2002) Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I–II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol 178(11):615–623PubMedCrossRefGoogle Scholar
  76. Polgar C, Fodor J, Major T et al (2007) Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69(3):694–702PubMedCrossRefGoogle Scholar
  77. Polgár C, Van Limbergen E, Pötter R et al (2010a) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence. Radiother Oncol 94(3):264–273PubMedCrossRefGoogle Scholar
  78. Polgár C, Major T, Fodor J et al (2010b) Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 94(3):274–279PubMedCrossRefGoogle Scholar
  79. Radiation Therapy Oncology Group (2005) RTOG 0413 broadcast, NSABP B-39/RTOG 0413: a randomized Phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with Stage 0, I, or II breast cancer. activated March 21, 2005. http://www.rtog.org/members/protocols/0413/0413broadcast.html. Accessed 16 July 2010
  80. Radiation Therapy Oncology Group (2010) RTOG 1014 broadcast: a phase II study of repeat breast preserving surgery and 3d-conformal partial breast re-irradiation (PBrI) for local recurrence of breast carcinoma. Activated June 4, 2010. http://rtog.org/members/protocols/1014/1014.pdf. Accessed 10 Dec 2010
  81. Remouchamps VM, Vicini FA, Sharpe MB et al (2003) Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 55(2):392–406PubMedCrossRefGoogle Scholar
  82. Richardson SL, Pino R (2010) Dosimetric effects of an air cavity for the SAVI partial breast irradiation applicator. Med Phys 37(8):3919–3926PubMedCrossRefGoogle Scholar
  83. Rivard MJ, Davis SD, DeWerd LA et al (2006) Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources. Med Phys 33(11):4020–4032PubMedCrossRefGoogle Scholar
  84. Rusthoven KE, Carter DL, Howell K et al (2008) Accelerated partial-breast intensity-modulated radiotherapy results in improved dose distribution when compared with three-dimensional treatment-planning techniques. Int J Radiat Oncol Biol Phys 70(1):296–302PubMedCrossRefGoogle Scholar
  85. Shaitelman SF, Vicini FA, Grills IS et al (2010) Differences in effective target volume between various techniques of accelerated partial breast. Int J Radiat Oncol Biol Phys Nov 1. [Epub ahead of print]Google Scholar
  86. Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Radiat Oncol Biol Phys 74(4):987–1001PubMedCrossRefGoogle Scholar
  87. Stolier A (2009) Surgical considerations in partial breast irradiation. In: Wazer D, Arthur D, Vicini F (eds) Accelerated partial breast irradiation: techniques and clinical implementation. Springer, Berlin, pp 59–72Google Scholar
  88. Uppsala-Oreboro Breast Cancer Study Group (1990) Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 82:277–282Google Scholar
  89. Vaidya JS (2009) APBI with 50 kV photons: targeted intraoperative radiotherapy (TARGIT). In: Wazer D, Arthur D, Vicini F (eds) Accelerated partial breast irradiation. Springer, Berlin, pp 327–344Google Scholar
  90. Vaidya JS, Vyas JJ, Chinoy RF et al (1996) Multicentricity of breast cancer: whole-organ implications. Br J Cancer 74:820–824PubMedCrossRefGoogle Scholar
  91. Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376(9735):91–102PubMedCrossRefGoogle Scholar
  92. Veronesi U, Marubini E, Marinani L et al (2001) Radiotherapy after breast conserving therapy in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12:1075–1080CrossRefGoogle Scholar
  93. Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232PubMedCrossRefGoogle Scholar
  94. Veronesi U, Orecchia R, Luini A et al (2005) Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 242(1):101–106PubMedCrossRefGoogle Scholar
  95. Veronesi U, Orecchia R, Luini A et al (2010) Intraoperative radiotherapy during breast conserving surgery: a study on 1, 822 cases treated with electrons. Breast Cancer Res Treat 124(1):141–151PubMedCrossRefGoogle Scholar
  96. Vicini FA, Arthur DW, Polgar C et al (2003) Defining the efficacy for accelerated partial breast irradiation: the important of proper patient selection, optimal quality assurance, and common sense. Int J Radiol Biol Phys 57:1210–1213CrossRefGoogle Scholar
  97. Vicini FA, Kestin LL, Goldstein NS et al (2004) Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys 60:722–730PubMedCrossRefGoogle Scholar
  98. Vicini FA, Beitsch PD, Quiet CA et al (2005) First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104:1138–1148PubMedCrossRefGoogle Scholar
  99. Vicini FA, Antonucci JV, Wallace M et al (2007) Long-term efficacy and patterns of failure after accelerate patial breat irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys 68(2):341–346PubMedCrossRefGoogle Scholar
  100. Vicini F, Arthur D, Wazer D et al (2010a) Limitations of the American society of therapeutic radiology and oncology consensus panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 79(4):977–984PubMedCrossRefGoogle Scholar
  101. Vicini FA, Winter K, Wong J et al (2010c) Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 77(4):1120–1127PubMedCrossRefGoogle Scholar
  102. Vicini F, Beitsch P, Quiet C et al (2011) Five-year analysis of treatment efficacy and cosmesis by the American society of breast surgeons Mammosite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 79(3):808–817Google Scholar
  103. Waljee JF, Hu ES, Newman LA et al (2008) Predictors of re-exision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 15:1287–1303CrossRefGoogle Scholar
  104. Wazer DE, Kaufman S, Cuttino L et al (2006) Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64:489–495PubMedCrossRefGoogle Scholar
  105. Whelan TJ, Pignol JP, Levine MN, et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 362(6):513–520PubMedCrossRefGoogle Scholar
  106. Wilkinson JB, Boyle T, Song J et al (2008) Surgeon-performed ultrasound reliably predicts skin spacing and may decrease the rate of MammoSite balloon catheter explantation in patients undergoing brachytherapy for breast cancer. Am J Surg 196(2):289–292PubMedCrossRefGoogle Scholar
  107. Wilkinson JB, Reid RE, Wallace M et al (2011). Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys [Epub ahead of print]Google Scholar
  108. Zannis V, Beitsch P, Vicini F et al (2005) Descriptions and outcomes of a breast brachytherapy balloon catheter in 1, 403 patients enrolled in the American society of breast surgeons MammoSite breast brachytherapy registry trial. Am J Surg 190(4):530–538PubMedCrossRefGoogle Scholar
  109. Zwicker RD, Arthur DW, Kavanagh BD et al (1999) Optimization of planar high-dose-rate implants. Int J Radiat Oncol Biol Phys 44:1171–1177PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Ben Wilkinson
    • 1
  • Laurie Cuttino
    • 2
  • Dorin Todor
    • 2
  • Frank Vicini
    • 1
  1. 1.Department of Radiation Oncology, Beaumont Cancer InstituteOakland University William Beaumont School of MedicineRoyal OakUSA
  2. 2.Department of Radiation Oncology, Massey Cancer CenterVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations